Trial report in Radiology. Imaging cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
5 citing papers in PubMed, 1 synthesis or guideline pooled it.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
8 authors.
Igor Makhlin *From the Department of Medicine, Division of Hematology & Oncology (I.M., A.S.C.), Department of Radiology, Division of Nuclear Medicine Imaging and Therapy (K.E.K., E.S., A.R.P., D.A.M.), Department of Biostatistics, Epidemiology, and Informatics (M.L.M.), Department of Radiology (J.G.), and Abramson Cancer Center (D.A.M., A.S.C.), University of Pennsylvania, 3400 Civic Center Blvd, South Tower, #10-156, Philadelphia, PA 19104.ORCID 0000-0001-7374-7330
Katrina Esther Korhonen *From the Department of Medicine, Division of Hematology & Oncology (I.M., A.S.C.), Department of Radiology, Division of Nuclear Medicine Imaging and Therapy (K.E.K., E.S., A.R.P., D.A.M.), Department of Biostatistics, Epidemiology, and Informatics (M.L.M.), Department of Radiology (J.G.), and Abramson Cancer Center (D.A.M., A.S.C.), University of Pennsylvania, 3400 Civic Center Blvd, South Tower, #10-156, Philadelphia, PA 19104.ORCID 0000-0002-0365-2640
Melissa Lynne MartinFrom the Department of Medicine, Division of Hematology & Oncology (I.M., A.S.C.), Department of Radiology, Division of Nuclear Medicine Imaging and Therapy (K.E.K., E.S., A.R.P., D.A.M.), Department of Biostatistics, Epidemiology, and Informatics (M.L.M.), Department of Radiology (J.G.), and Abramson Cancer Center (D.A.M., A.S.C.), University of Pennsylvania, 3400 Civic Center Blvd, South Tower, #10-156, Philadelphia, PA 19104.
Jennifer GillmanFrom the Department of Medicine, Division of Hematology & Oncology (I.M., A.S.C.), Department of Radiology, Division of Nuclear Medicine Imaging and Therapy (K.E.K., E.S., A.R.P., D.A.M.), Department of Biostatistics, Epidemiology, and Informatics (M.L.M.), Department of Radiology (J.G.), and Abramson Cancer Center (D.A.M., A.S.C.), University of Pennsylvania, 3400 Civic Center Blvd, South Tower, #10-156, Philadelphia, PA 19104.ORCID 0000-0002-8176-2757
Erin SchubertFrom the Department of Medicine, Division of Hematology & Oncology (I.M., A.S.C.), Department of Radiology, Division of Nuclear Medicine Imaging and Therapy (K.E.K., E.S., A.R.P., D.A.M.), Department of Biostatistics, Epidemiology, and Informatics (M.L.M.), Department of Radiology (J.G.), and Abramson Cancer Center (D.A.M., A.S.C.), University of Pennsylvania, 3400 Civic Center Blvd, South Tower, #10-156, Philadelphia, PA 19104.
Austin Ryan PantelFrom the Department of Medicine, Division of Hematology & Oncology (I.M., A.S.C.), Department of Radiology, Division of Nuclear Medicine Imaging and Therapy (K.E.K., E.S., A.R.P., D.A.M.), Department of Biostatistics, Epidemiology, and Informatics (M.L.M.), Department of Radiology (J.G.), and Abramson Cancer Center (D.A.M., A.S.C.), University of Pennsylvania, 3400 Civic Center Blvd, South Tower, #10-156, Philadelphia, PA 19104.ORCID 0000-0001-8649-9970
David A MankoffFrom the Department of Medicine, Division of Hematology & Oncology (I.M., A.S.C.), Department of Radiology, Division of Nuclear Medicine Imaging and Therapy (K.E.K., E.S., A.R.P., D.A.M.), Department of Biostatistics, Epidemiology, and Informatics (M.L.M.), Department of Radiology (J.G.), and Abramson Cancer Center (D.A.M., A.S.C.), University of Pennsylvania, 3400 Civic Center Blvd, South Tower, #10-156, Philadelphia, PA 19104.ORCID 0000-0002-6971-5413
Amy S ClarkFrom the Department of Medicine, Division of Hematology & Oncology (I.M., A.S.C.), Department of Radiology, Division of Nuclear Medicine Imaging and Therapy (K.E.K., E.S., A.R.P., D.A.M.), Department of Biostatistics, Epidemiology, and Informatics (M.L.M.), Department of Radiology (J.G.), and Abramson Cancer Center (D.A.M., A.S.C.), University of Pennsylvania, 3400 Civic Center Blvd, South Tower, #10-156, Philadelphia, PA 19104.ORCID 0000-0002-3685-6535
Funding
CANCER RESEARCH TRAINING PROGRAMT32CA009615 · NCI · UNIVERSITY OF PENNSYLVANIA · PI Gregory L Beatty, MICHAEL D HOGARTY · 1988 to 2026
$10.4M
NCI NIH HHS T32 CA009615
6 · The paper itself
Abstract
Fluorine 18 (
Indexed as
Bone NeoplasmsBreast NeoplasmsAdultAgedAged, 80 and overEstrogensFemaleFluorineFluorodeoxyglucose F18HumansMiddle AgedPositron Emission Tomography Computed TomographyProspective StudiesReceptors, EstrogenEstrogensFluorineFluorodeoxyglucose F18Receptors, EstrogenBone-Dominant Metastatic Breast CancerBreast CancerEstrogen-Receptor Positive Metastatic Breast CancerFDG PET/CTMetastatic Breast Cancer
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.